Related Experiment Videos
[Isolated primary hyperaldosteronism caused by adrenocortical carcinoma]
A Parajó1, J L Fírvida, E Otero
1Servicio de Cirugía, Hospital Santa María Nai, Orense, España.
Archivos Espanoles De Urologia
|February 24, 2001
Summary
Adrenocortical carcinoma presenting solely with primary aldosteronism is rare. This case highlights challenges in diagnosis and treatment, with metastasis occurring despite initial surgical success and adjuvant therapy.
Area of Science:
- Endocrinology
- Oncology
- Surgical Pathology
Background:
- Adrenocortical carcinoma (ACC) is a rare malignancy.
- Primary aldosteronism (PA) is typically caused by benign adrenal adenomas.
- Co-occurrence of ACC and PA as the sole endocrine manifestation is exceptionally uncommon.
Observation:
- A 39-year-old male presented with ACC and isolated PA.
- Initial treatment involved right adrenalectomy and nephrectomy (stage II).
- Post-surgery, hormonal levels normalized, but lung metastasis developed 15 months later, with PA recurrence.
Findings:
- The patient received adjuvant carboplatin and etoposide.
- Recurrent disease showed no response to spironolactone, 5-FU, and adriamycin.
- The patient died 3 years post-diagnosis due to metastatic disease complications.
Implications:
- This case underscores the diagnostic and therapeutic complexities of ACC with isolated PA.
- Adjuvant therapy with platinum-based agents (e.g., cisplatin and etoposide) may be considered for advanced stages.
- Further research is needed to establish optimal treatment strategies for this rare presentation.